Ignite Creation Date:
2024-05-05 @ 11:44 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00111982
Status:
COMPLETED
Last Update Posted:
2010-02-26
First Post:
2005-05-27
Brief Title:
Trial of Extended Treatment With Liatermin r-metHuGDNF Administered by Continuous Intraputaminal IPuInfusion to Subjects With Idiopathic Parkinsons Disease Who Have Completed a Previous Trial of Liatermin
Sponsor:
Amgen
Organization:
Amgen
Study Overview
Official Title:
Multi-Center Open-Label Trial of Extended Treatment With Liatermin r-metHuGDNF Administered by Continuous Intraputaminal IPu Infusion to Subjects With Idiopathic Parkinsons Disease Who Have Completed a Previous Trial of Liatermin Protocol 20020168
Status:
COMPLETED
Status Verified Date:
2010-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine long-term efficacy of continuous IPu liatermin infusion administered with concomitant standard anti-Parkinsonian therapy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None